Companies /Healthcare

Acadia Pharmaceuticals Inc

NASDAQ: ACAD Biotechnology
$28.91
▼ $0.20 (−0.69%) today
Markets closed · 7:13pm ET

ACAD Coverage

Page 4
9:10am ET
Health and Healthcare

Acadia Posts Big Win With FDA Approval

Acadia Pharmaceuticals saw its shares on the rise again this week following an incredibly positive FDA vote on its Parkinson's treatment.

Chris Lange
11:35am ET
Health and Healthcare

Why Merrill Lynch Sees Acadia Rising Another 60%

Shares of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) surged early on Monday morning. This company is under the spotlight by the U.S. Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee, which is set to…

Chris Lange
10:35am ET
Health and Healthcare

5 Key FDA Decisions Expected in March

24/7 Wall St. has collected three big FDA decisions coming up in March and added some color, along with the trading range and price target.

Chris Lange